This Senator Just Bought Up To $100K In Artivion Stock

The Office of Senator Tina Smith reported a purchase of Artivion AORT stock on October 17, 2022. According to the October filing, the transaction was made on October 17, 2022.

What Happened: A Periodic Transaction Report from the U.S. Senate's Office on October 17, 2022 showed that Smith bought $50,001 - $100,000 of Artivion stock.

Artivion shares are trading down 0.7% at $10.92 at the time of writing.

Why Congressional Transactions Matter

Congressional transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.

A Congressional transaction is when any Representative or Senator either buys or sells an individual stock. Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.

When a Senator or Representative makes a new purchase, that could be an indication that they expect the stock to rise.

A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.

Trade Recap

A October filing states that Senator Tina Smith bought shares of Artivion. The exact amount of the transaction remained unknown but the filing states a range of $50,001 - $100,000.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: GovernmentNewsPoliticsTrading IdeasGeneralBZI-GT
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!